Denali Therapeutics (DNLI) announced Monday that the company and partner Biogen (BIIB) would halt a Phase 3 trial for Parkinson's disease
https://seekingalpha.com/news/3977588-biogen-denali-halt-trial-parkinsons-disease-drug
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.